Skip to main content
Home

Language & Country Selector for Desktop

language-selector-globe Philippines | en

Choose Location

  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
  • Argentina | es
  • Venezuela | es
  • Brazil | pt
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Mexico | es
  • United States | en
  • Australia | en
  • Bangladesh | en
  • Hong Kong S.A.R. | zh
  • India | en
  • Indonesia | en
  • Japan | ja
  • Korea | ko
  • Mainland China | zh
  • Malaysia | en
  • Pakistan | en
  • Philippines | en
  • Singapore | en
  • Taiwan | zh
  • Austria | de
  • Belgium | fr
  • Bulgaria | bg
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Greece | el
  • Hungary | hu
  • Ireland | en
  • Italy | it
  • Latvia | lv
  • Lithuania | lt
  • Netherlands | nl
  • Norway | no
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Serbia | sr
  • Slovakia | sk
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • United Kingdom | en
  • Global | en
  • Sandoz | en
  • Novartis Foundation | en
  • Egypt | en
  • South Africa | en
  • Turkey | tr

Language & Country Selector for Mobile

language-selector-globe Philippines

Choose Location

Americas Asia Pacific Europe International Middle East & Africa
  • Argentina | es
  • Venezuela | es
  • Australia | en
  • Austria | de
  • Bangladesh | en
  • Belgium | fr
  • Brazil | pt
  • Bulgaria | bg
  • Canada | en
  • Canada | fr
  • Central America | es
  • Colombia | es
  • Czech Republic | cs
  • Czech Republic | en
  • Denmark | da
  • Egypt | en
  • Estonia | et
  • Finland | fi
  • France | fr
  • Germany | de
  • Global | en
  • Greece | el
  • Hong Kong S.A.R. | zh
  • Hungary | hu
  • India | en
  • Indonesia | en
  • Ireland | en
  • Italy | it
  • Japan | ja
  • Korea | ko
  • Latvia | lv
  • Lithuania | lt
  • Mainland China | zh
  • Malaysia | en
  • Mexico | es
  • Netherlands | nl
  • Norway | no
  • Pakistan | en
  • Philippines | en
  • Poland | pl
  • Portugal | pt
  • Romania | ro
  • Russia | ru
  • Sandoz | en
  • Novartis Foundation | en
  • Serbia | sr
  • Singapore | en
  • Slovakia | sk
  • South Africa | en
  • Spain | es
  • Sweden | sv
  • Switzerland | de
  • Switzerland | fr
  • Taiwan | zh
  • Turkey | tr
  • United Kingdom | en
  • United States | en
    • About 
      • Novartis in Philippines 
      • Strategy 
      • Diversity and Inclusion 
      • People and Culture 
      • Products 
      • Country Leadership Team 
      • Contact 
      About
    • Patients and Caregivers 
      • Novartis Commitment to Patients and Caregivers 
      • Diseases 
      • Patient resources 
      • Products 
      • Adverse Event Reporting 
      Patients and Caregivers
    • Healthcare Professionals 
      • Healthcare professional country resource 
      • Products 
      • Novartis Pipeline 
      • Adverse Event Reporting 
      • Novartis Clinical Trials 
      Healthcare Professionals
    • ESG 
      • Ethical Behavior 
        • Code of Ethics 
        • SpeakUp 
      • Ethics, Risk and Compliance 
      • Access 
      • Environmental Sustainability 
      • Global Health 
      ESG
    • News 
      • News Archive 
      • Stories 
      • Contacts 
      News
    • Careers 
      • Career Search 
      • Meet the teams 
      • Personal Growth 
      • Early Talent 
      • How We Work 
      • Well-being 
      • Diversity and Inclusion 
      • Career Programs 
      • Awards and Recognition 
      Careers
    • Coronavirus 
      Coronavirus
    Home

Stories

  • Novartis Philippines launches PIK3CA Testing Program for Breast Cancer 2.jpeg
    Sep 23, 2022
    Novartis supports the Southeast Asian Breast Cancer Symposium
  • Meeting of People
    Education & Awareness
    Mar 14, 2022
    Asia Pacific Patient Innovation Summit: Philippines Outcome Report 2021
    Education & Awareness
  • World Spine Day
    Education & Awareness
    Mar 2, 2022
    Bamboo Spine in Ankylosing Spondylitis
    Education & Awareness
  • Caring For Employee Mental Health
    Education & Awareness
    Mar 2, 2022
    Mental Health, Migraine and Workplace Culture in the time of COVID-19
    Education & Awareness
  • Image: Filipino Delegates to the Novartis Next Generation Scientist Program and Biotechnology Leadership Camp
    Hope
    Mar 2, 2022
    Building A Science And Innovation Nation
    Hope

Novartis Philippines

Navigate Novartis
  • Patients & Caregivers
  • Healthcare Professionals
  • ESG
  • News
  • Careers
Media Center
  • News Archive
  • Stories
Our Portfolio
  • Novartis Clinical Pipeline
  • Novartis Product Portfolio
Footer Bottom
© 2022 Novartis AG
  • Privacy Policy
  • Terms of Use
  • Cookie Settings
  • Site Map
  • Web Accessibility
Novartis Site Directory
This site is intended for an audience in the Philippines